Blood protein CXCL2 shows strong accuracy detecting endometrial cancer before surgery
A prospective case-control study found preoperative serum CXCL2 discriminated endometrial cancer from benign gynecologic disease with an AUC of 0.923, ...
A prospective case-control study found preoperative serum CXCL2 discriminated endometrial cancer from benign gynecologic disease with an AUC of 0.923, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.